Peter J. Flor

9.4k total citations · 3 hit papers
86 papers, 7.4k citations indexed

About

Peter J. Flor is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Behavioral Neuroscience. According to data from OpenAlex, Peter J. Flor has authored 86 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Cellular and Molecular Neuroscience, 39 papers in Molecular Biology and 11 papers in Behavioral Neuroscience. Recurrent topics in Peter J. Flor's work include Neuroscience and Neuropharmacology Research (61 papers), Receptor Mechanisms and Signaling (22 papers) and Stress Responses and Cortisol (11 papers). Peter J. Flor is often cited by papers focused on Neuroscience and Neuropharmacology Research (61 papers), Receptor Mechanisms and Signaling (22 papers) and Stress Responses and Cortisol (11 papers). Peter J. Flor collaborates with scholars based in Switzerland, Germany and United States. Peter J. Flor's co-authors include F. Gasparini, Herman van der Putten, John F. Cryan, Ralf Kühn, Rainer Kühn, Natacha Stoehr, Ivo Vranesic, Ryuichi Shigemoto, Noboru Mizuno and Akio Neki and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Peter J. Flor

82 papers receiving 7.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Differential Presynaptic Localization of Metabotropic Glutamate Receptor Subtypes in the Rat Hippocampus

1997 953 citations Peter J. Flor et al. profile →
Expression cloning of GABAB receptors uncovers similarity to metabotropic glutamate receptors

1997 831 citations Klemens Kaupmann, Jakob Heid et al. Nature profile →
2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist

1999 628 citations F. Gasparini, Kurt Lingenhöhl et al. Neuropharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter J. Flor Switzerland	42	5.6k	4.1k	1.2k	694	598	86	7.4k
Ruth M. McKernan United Kingdom	47	6.4k 1.2×	4.5k 1.1×	1.7k 1.4×	638 0.9×	947 1.6×	100	8.5k
Klemens Kaupmann Switzerland	46	6.3k 1.1×	5.1k 1.2×	952 0.8×	811 1.2×	440 0.7×	95	8.8k
David R. Burt United States	33	6.5k 1.2×	4.8k 1.2×	771 0.7×	672 1.0×	407 0.7×	91	9.0k
Hartmut Lüddens Germany	34	4.9k 0.9×	3.2k 0.8×	1.1k 0.9×	319 0.5×	652 1.1×	83	6.0k
Pari Malherbe Switzerland	43	4.2k 0.7×	3.5k 0.9×	869 0.7×	594 0.9×	471 0.8×	80	5.6k
Esa R. Korpi Finland	57	7.6k 1.4×	4.6k 1.1×	1.9k 1.6×	988 1.4×	1.0k 1.7×	299	10.5k
F. Anne Stephenson United Kingdom	47	6.2k 1.1×	5.3k 1.3×	1.0k 0.9×	638 0.9×	807 1.3×	115	7.9k
Dolan B. Pritchett United States	35	5.9k 1.1×	4.6k 1.1×	922 0.8×	345 0.5×	573 1.0×	45	7.3k
H.A. Robertson Canada	54	6.2k 1.1×	4.0k 1.0×	1.1k 1.0×	1.1k 1.6×	464 0.8×	159	9.5k
Wolfgang Froestl Switzerland	44	5.5k 1.0×	4.3k 1.1×	672 0.6×	1.0k 1.5×	279 0.5×	92	7.3k

Countries citing papers authored by Peter J. Flor

Since Specialization

Citations

This map shows the geographic impact of Peter J. Flor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. Flor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. Flor more than expected).

Fields of papers citing papers by Peter J. Flor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter J. Flor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. Flor. The network helps show where Peter J. Flor may publish in the future.

Co-authorship network of co-authors of Peter J. Flor

This figure shows the co-authorship network connecting the top 25 collaborators of Peter J. Flor. A scholar is included among the top collaborators of Peter J. Flor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter J. Flor. Peter J. Flor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brabet, Isabelle, Ralf Glatthar, Cyril Goudet, et al.. (2024). Novel Inhibitory Site Revealed by XAP044 Mode of Action on the Metabotropic Glutamate 7 Receptor Venus Flytrap Domain. Journal of Medicinal Chemistry. 67(14). 11662–11687. 3 indexed citations

Slattery, David A., Inga D. Neumann, Peter J. Flor, & Iulia Zoicas. (2017). Pharmacological modulation of metabotropic glutamate receptor subtype 5 and 7 impairs extinction of social fear in a time-point-dependent manner. Behavioural Brain Research. 328. 57–61. 9 indexed citations

Iacovelli, Luisa, Luisa Di Menna, Daniel Peterlik, et al.. (2016). Type-7 metabotropic glutamate receptors negatively regulate α1-adrenergic receptor signalling. Neuropharmacology. 113(Pt A). 343–353. 3 indexed citations

Gee, Christine E., Daniel Peterlik, Rochdi Bouhelal, et al.. (2014). Blocking Metabotropic Glutamate Receptor Subtype 7 (mGlu7) via the Venus Flytrap Domain (VFTD) Inhibits Amygdala Plasticity, Stress, and Anxiety-related Behavior. Journal of Biological Chemistry. 289(16). 10975–10987. 64 indexed citations

O’Connor, Richard M., Beate C. Finger, Peter J. Flor, & John F. Cryan. (2010). Metabotropic glutamate receptor 7: At the interface of cognition and emotion. European Journal of Pharmacology. 639(1-3). 123–131. 72 indexed citations

Flor, Peter J., et al.. (2008). Amygdaloid metabotropic glutamate receptor subtype 7 is involved in the acquisition of conditioned fear. Neuroreport. 19(11). 1147–1150. 33 indexed citations

Hoyer, Daniël, Deepak R. Thakker, François Natt, et al.. (2006). Global Down-Regulation of Gene Expression in the Brain Using RNA Interference, with Emphasis on Monoamine Transporters and GPCRs: Implications for Target Characterization in Psychiatric and Neurological Disorders. Journal of Receptors and Signal Transduction. 26(5-6). 527–547. 19 indexed citations

Cryan, John F., Peter H. Kelly, H.C. Neijt, et al.. (2003). Antidepressant and anxiolytic‐like effects in mice lacking the group III metabotropic glutamate receptor mGluR7. European Journal of Neuroscience. 17(11). 2409–2417. 220 indexed citations

Gasparini, F., Hendrik Andres, Peter J. Flor, et al.. (2002). [3H]-M-MPEP, a Potent, Subtype-Selective Radioligand for the Metabotropic Glutamate Receptor Subtype 5. Bioorganic & Medicinal Chemistry Letters. 12(3). 407–409. 63 indexed citations

10.

Pellicciari, Roberto, Gabriele Costantino, Maura Marinozzi, et al.. (2001). Design, synthesis and preliminary evaluation of novel 3′-Substituted carboxycyclopropylglycines as antagonists at group 2 metabotropic glutamate receptors. Bioorganic & Medicinal Chemistry Letters. 11(24). 3179–3182. 20 indexed citations

11.

Walker, Katherine, Moh Panesar, Davis Aj, et al.. (2001). Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function. Neuropharmacology. 40(1). 1–9. 140 indexed citations

12.

Amori, Laura, Gabriele Costantino, Maura Marinozzi, et al.. (2000). Synthesis, molecular modeling and preliminary biological evaluation of 1-amino-3-phosphono-3-cyclopentene-1-carboxylic acid and 1-amino-3-phosphono-2-cyclopentene-1-carboxylic acid, two novel agonists of metabotropic glutamate receptors of group III. Bioorganic & Medicinal Chemistry Letters. 10(13). 1447–1450. 25 indexed citations

13.

Gasparini, F., Valeria Bruno, Giuseppe Battaglia, et al.. (1999). (R, S)-4-Phosphonophenylglycine, a Potent and Selective Group III Metabotropic Glutamate Receptor Agonist, Is Anticonvulsive and Neuroprotective In Vivo. Journal of Pharmacology and Experimental Therapeutics. 289(3). 1678–1687. 143 indexed citations

14.

Lin, Fen‐Fen, Mark A. Varney, Aida Sacaan, et al.. (1997). Cloning and stable expression of the mGluR1b subtype of human metabotropic receptors and pharmacological comparison with the mGluR5a subtype. Neuropharmacology. 36(7). 917–931. 42 indexed citations

15.

Kaupmann, Klemens, Jakob Heid, Peter J. Flor, et al.. (1997). Expression cloning of GABAB receptors uncovers similarity to metabotropic glutamate receptors. Nature. 386(6622). 239–246. 831 indexed citations breakdown →

16.

Flor, Peter J., et al.. (1995). Molecular Cloning, Functional Expression and Pharmacological Characterization of the Human Metabotropic Glutamate Receptor Type 2. European Journal of Neuroscience. 7(4). 622–629. 72 indexed citations

17.

Fredman, Brian, et al.. (1994). Residual pneumoperitoneum: a cause of postoperative pain after laparoscopic cholecystectomy.. PubMed. 79(1). 152–4. 113 indexed citations

18.

Flor, Peter J.. (1969). On groups of non-negative matrices. French digital mathematics library (Numdam). 41 indexed citations

19.

Debrunner, Hans & Peter J. Flor. (1964). Ein Erweiterungssatz für monotone Mengen. Archiv der Mathematik. 15(1). 445–447. 38 indexed citations

20.

Flor, Peter J.. (1963). �ber die Wertmengen fastperiodischer Folgen. Monatshefte für Mathematik. 67(1). 12–17. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact